Stay updated on VELIA Clinical Trial: Veliparib in Ovarian Cancer
Sign up to get notified when there's something new on the VELIA Clinical Trial: Veliparib in Ovarian Cancer page.

Latest updates to the VELIA Clinical Trial: Veliparib in Ovarian Cancer page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added and the previous v3.4.1 revision plus a government funding status notice were removed. This update does not alter core study details or page content.SummaryDifference0.1%

- Check21 days agoChange DetectedA government funding lapse notice with operation-status information was added, and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.1%

- Check28 days agoChange DetectedIntroduces a Show glossary option and a Revision: v3.4.0 tag, and updates labels for QC criteria and the No FEAR Act notice with capitalization tweaks.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.3.4 is now shown, replacing the previous Revision: v3.3.3.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page's Locations section has been expanded to include a large number of sites across multiple regions, broadening geographic coverage for the study.SummaryDifference2%

- Check92 days agoChange DetectedPublications section text updated: it now states that publications are automatically filled from PubMed and includes Revision: v3.3.2, while the previous PubMed description and Revision: v3.2.0 are removed.SummaryDifference0.0%

Stay in the know with updates to VELIA Clinical Trial: Veliparib in Ovarian Cancer
Enter your email address, and we'll notify you when there's something new on the VELIA Clinical Trial: Veliparib in Ovarian Cancer page.